...
首页> 外文期刊>Drug development and industrial pharmacy >Preparation and characterization of mucoadhesive nanoparticles of poly (methyl vinyl ether-co-maleic anhydride) containing glycyrrhizic acid intended for vaginal administration
【24h】

Preparation and characterization of mucoadhesive nanoparticles of poly (methyl vinyl ether-co-maleic anhydride) containing glycyrrhizic acid intended for vaginal administration

机译:用于阴道给药的含甘草酸的聚(甲基乙烯基醚-马来酸酐共聚物)粘膜粘附性纳米颗粒的制备与表征

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Traditional vaginal preparations reside in the vaginal cavity for relatively a short period of time, requiring multiple doses in order to attain the desired therapeutic effect. Therefore, mucoadhesive systems appear to be appropriate to prolong the residence time in the vaginal cavity. In the current study, mucoadhesive nanoparticles based on poly(methyl vinyl ether-co-maleic anhydride) (PVM/MA) intended for vaginal delivery of glycyrrhizic acid (GA) (a drug with well-known antiviral properties) were prepared and characterized. Nanoparticles were generated by a solvent displacement method. Incorporation of GA was performed during nanoprecipitation, followed by adsorption of drug once nanoparticles were formed. The prepared nanoparticles were characterized in terms of size, Z-potential, morphology, drug loading, interaction of GA with PVM/MA (by differential scanning calorimetry) and the in vitro interaction of nanoparticles with pig mucin (at two pH values, 3.6 and 5; with and without GA adsorbed). The preparation method led to nanoparticles of a mean diameter of 198.5 +/- 24.3 nm, zeta potential of -44.8 +/- 2.8mV and drug loading of 15.07 +/- 0.86 mu g/mg polymer. The highest mucin interaction resulted at pH 3.6 for nanoparticles without GA adsorbed. The data obtained suggest the promise of using mucoadhesive nanoparticles of PVM/MA for intravaginal delivery of GA.
机译:传统的阴道制剂在阴道腔中停留的时间相对较短,需要多次剂量才能达到理想的治疗效果。因此,粘膜粘附系统似乎适合延长阴道腔内的停留时间。在当前的研究中,制备并表征了基于聚(甲基乙烯基醚-顺丁烯二酸酐)(PVM / MA)的粘膜粘附纳米颗粒,旨在通过阴道递送甘草酸(GA)(一种具有众所周知的抗病毒特性的药物)进行表征。通过溶剂置换法产生纳米粒子。 GA的掺入是在纳米沉淀过程中进行的,一旦形成纳米颗粒,便会吸附药物。制备的纳米颗粒通过尺寸,Z电位,形态,药物载量,GA与PVM / MA的相互作用(通过差示扫描量热法)以及纳米颗粒与猪粘蛋白的体外相互作用(在两个pH值,3.6和pH下)进行表征。 5;有和没有GA吸附)。该制备方法导致纳米颗粒的平均直径为198.5 +/- 24.3nm,ζ电势为-44.8 +/- 2.8mV,药物载量为15.07 +/-0.86μg/ mg聚合物。对于没有GA吸附的纳米颗粒,在pH 3.6时产生的粘液相互作用最高。获得的数据表明使用PVM / MA的粘膜粘附性纳米颗粒进行GA的阴道内递送的希望。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号